 David Brumbaugh
Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medical Marijuana | 2 | 2021 | 97 | 1.250 |
Why?
| | Foreign Bodies | 5 | 2020 | 93 | 1.090 |
Why?
| | Esophagus | 4 | 2018 | 224 | 0.880 |
Why?
| | Advisory Committees | 2 | 2020 | 206 | 0.790 |
Why?
| | Clostridium Infections | 2 | 2023 | 53 | 0.760 |
Why?
| | Fatty Liver | 2 | 2013 | 209 | 0.730 |
Why?
| | Muscular Dystrophy, Duchenne | 2 | 2018 | 78 | 0.710 |
Why?
| | Organizational Policy | 1 | 2020 | 67 | 0.680 |
Why?
| | Specialties, Surgical | 1 | 2020 | 66 | 0.660 |
Why?
| | Esophagoscopy | 2 | 2018 | 181 | 0.650 |
Why?
| | Fecal Microbiota Transplantation | 2 | 2023 | 13 | 0.630 |
Why?
| | Nutrition Disorders | 1 | 2018 | 22 | 0.620 |
Why?
| | Electric Power Supplies | 4 | 2020 | 46 | 0.620 |
Why?
| | Dilatation | 1 | 2018 | 58 | 0.610 |
Why?
| | Esophageal Stenosis | 1 | 2018 | 45 | 0.600 |
Why?
| | Epidermolysis Bullosa | 1 | 2018 | 41 | 0.600 |
Why?
| | Fluoroscopy | 1 | 2018 | 140 | 0.590 |
Why?
| | Hospitals, Pediatric | 2 | 2021 | 480 | 0.580 |
Why?
| | Feces | 2 | 2017 | 369 | 0.570 |
Why?
| | Surgeons | 1 | 2020 | 235 | 0.540 |
Why?
| | Diarrhea | 1 | 2017 | 170 | 0.540 |
Why?
| | Gastrointestinal Diseases | 1 | 2018 | 181 | 0.540 |
Why?
| | Pharynx | 1 | 2016 | 52 | 0.520 |
Why?
| | Intestines | 2 | 2016 | 324 | 0.510 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 118 | 0.500 |
Why?
| | Informed Consent | 1 | 2016 | 158 | 0.470 |
Why?
| | Endoscopy, Gastrointestinal | 2 | 2016 | 201 | 0.460 |
Why?
| | Gastroenterology | 1 | 2016 | 159 | 0.440 |
Why?
| | Gastrointestinal Hemorrhage | 2 | 2011 | 100 | 0.420 |
Why?
| | Hyperbilirubinemia | 1 | 2012 | 14 | 0.400 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2013 | 141 | 0.390 |
Why?
| | Muscle Cells | 1 | 2012 | 41 | 0.390 |
Why?
| | Microbiota | 2 | 2016 | 646 | 0.390 |
Why?
| | Diabetes, Gestational | 2 | 2012 | 281 | 0.380 |
Why?
| | Child | 12 | 2023 | 18340 | 0.380 |
Why?
| | Intra-Abdominal Fat | 1 | 2012 | 77 | 0.380 |
Why?
| | Esophageal Diseases | 1 | 2011 | 24 | 0.370 |
Why?
| | Obesity | 2 | 2013 | 2501 | 0.360 |
Why?
| | Adiposity | 2 | 2012 | 458 | 0.360 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 472 | 0.360 |
Why?
| | Infant | 7 | 2020 | 7922 | 0.340 |
Why?
| | Lipid Metabolism | 1 | 2012 | 438 | 0.320 |
Why?
| | Energy Metabolism | 1 | 2013 | 717 | 0.310 |
Why?
| | Pediatrics | 1 | 2016 | 981 | 0.300 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2013 | 453 | 0.300 |
Why?
| | Neoplasms | 1 | 2021 | 2082 | 0.280 |
Why?
| | Child, Preschool | 9 | 2020 | 9093 | 0.280 |
Why?
| | Hemorrhage | 1 | 2011 | 599 | 0.280 |
Why?
| | Liver | 1 | 2013 | 1630 | 0.260 |
Why?
| | Humans | 25 | 2023 | 113531 | 0.250 |
Why?
| | Insulin Resistance | 1 | 2012 | 1068 | 0.220 |
Why?
| | Vascular Fistula | 2 | 2016 | 14 | 0.220 |
Why?
| | Esophageal Fistula | 2 | 2016 | 17 | 0.220 |
Why?
| | Adolescent | 6 | 2023 | 17724 | 0.210 |
Why?
| | Retrospective Studies | 5 | 2023 | 12504 | 0.200 |
Why?
| | Mineral Oil | 1 | 2002 | 2 | 0.200 |
Why?
| | Pneumonia, Aspiration | 1 | 2002 | 15 | 0.200 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3013 | 0.190 |
Why?
| | Brain Abscess | 1 | 2021 | 10 | 0.190 |
Why?
| | Parents | 2 | 2021 | 1175 | 0.180 |
Why?
| | Female | 12 | 2020 | 59115 | 0.180 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 1725 | 0.180 |
Why?
| | Diagnostic Errors | 1 | 2021 | 150 | 0.180 |
Why?
| | Federal Government | 1 | 2020 | 26 | 0.180 |
Why?
| | State Government | 1 | 2020 | 41 | 0.170 |
Why?
| | Recurrence | 3 | 2023 | 925 | 0.170 |
Why?
| | Male | 11 | 2021 | 55112 | 0.170 |
Why?
| | Morbidity | 1 | 2020 | 275 | 0.170 |
Why?
| | Pregnancy | 4 | 2016 | 5490 | 0.170 |
Why?
| | Legislation, Drug | 1 | 2020 | 78 | 0.160 |
Why?
| | Treatment Outcome | 5 | 2023 | 9006 | 0.160 |
Why?
| | Infant, Newborn | 3 | 2016 | 5032 | 0.160 |
Why?
| | Single-Balloon Enteroscopy | 1 | 2018 | 4 | 0.160 |
Why?
| | Medical Oncology | 1 | 2021 | 229 | 0.160 |
Why?
| | Magnets | 1 | 2018 | 15 | 0.160 |
Why?
| | Patient Safety | 1 | 2021 | 272 | 0.150 |
Why?
| | Body Composition | 2 | 2012 | 584 | 0.150 |
Why?
| | Nutritional Requirements | 1 | 2018 | 73 | 0.150 |
Why?
| | Endocrine System | 1 | 2018 | 19 | 0.150 |
Why?
| | Intestine, Small | 1 | 2018 | 121 | 0.150 |
Why?
| | Neuromuscular Junction | 1 | 2018 | 52 | 0.140 |
Why?
| | Intubation, Gastrointestinal | 1 | 2017 | 54 | 0.140 |
Why?
| | Stomach | 1 | 2017 | 100 | 0.140 |
Why?
| | Down Syndrome | 1 | 2002 | 335 | 0.140 |
Why?
| | Gastrostomy | 1 | 2017 | 89 | 0.140 |
Why?
| | Quality Improvement | 2 | 2020 | 951 | 0.130 |
Why?
| | Nutritional Status | 1 | 2018 | 286 | 0.130 |
Why?
| | Gastrointestinal Tract | 1 | 2018 | 168 | 0.130 |
Why?
| | Colonoscopy | 1 | 2017 | 197 | 0.120 |
Why?
| | Referral and Consultation | 1 | 2020 | 632 | 0.120 |
Why?
| | Risk Factors | 3 | 2013 | 8606 | 0.120 |
Why?
| | Cohort Studies | 2 | 2017 | 4880 | 0.120 |
Why?
| | Rectum | 1 | 2016 | 151 | 0.120 |
Why?
| | Disclosure | 1 | 2016 | 100 | 0.120 |
Why?
| | Vagina | 1 | 2016 | 146 | 0.120 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 970 | 0.120 |
Why?
| | Young Adult | 2 | 2020 | 10400 | 0.120 |
Why?
| | Colorado | 2 | 2020 | 4061 | 0.110 |
Why?
| | Disease Management | 1 | 2018 | 554 | 0.110 |
Why?
| | Sequence Analysis, DNA | 1 | 2016 | 716 | 0.110 |
Why?
| | Cholestasis, Extrahepatic | 1 | 2012 | 5 | 0.100 |
Why?
| | Hepatolenticular Degeneration | 1 | 2012 | 16 | 0.100 |
Why?
| | Choledochal Cyst | 1 | 2012 | 17 | 0.100 |
Why?
| | Gallstones | 1 | 2012 | 28 | 0.100 |
Why?
| | Biliary Tract Diseases | 1 | 2012 | 33 | 0.100 |
Why?
| | Hepatitis A | 1 | 2012 | 26 | 0.100 |
Why?
| | Alagille Syndrome | 1 | 2012 | 35 | 0.100 |
Why?
| | Skin | 1 | 2016 | 650 | 0.100 |
Why?
| | Aspartate Aminotransferases | 1 | 2012 | 84 | 0.100 |
Why?
| | Bilirubin | 1 | 2012 | 88 | 0.100 |
Why?
| | Intracellular Space | 1 | 2012 | 67 | 0.100 |
Why?
| | Alanine Transaminase | 1 | 2012 | 140 | 0.100 |
Why?
| | Puberty | 1 | 2012 | 131 | 0.090 |
Why?
| | Neonatal Screening | 1 | 2012 | 151 | 0.090 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2013 | 244 | 0.090 |
Why?
| | Biliary Atresia | 1 | 2012 | 186 | 0.080 |
Why?
| | Liver Diseases | 1 | 2012 | 254 | 0.080 |
Why?
| | Epigenesis, Genetic | 1 | 2013 | 515 | 0.080 |
Why?
| | Jejunal Diseases | 1 | 2009 | 7 | 0.080 |
Why?
| | Decision Making | 1 | 2016 | 761 | 0.080 |
Why?
| | Capsule Endoscopy | 1 | 2009 | 17 | 0.080 |
Why?
| | Trachea | 1 | 2011 | 220 | 0.080 |
Why?
| | Autoimmune Diseases | 1 | 2012 | 379 | 0.080 |
Why?
| | Aorta | 1 | 2011 | 377 | 0.080 |
Why?
| | Metformin | 1 | 2012 | 273 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2012 | 1328 | 0.070 |
Why?
| | Adult | 3 | 2023 | 30245 | 0.070 |
Why?
| | Phenotype | 1 | 2013 | 2754 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2012 | 2752 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2077 | 0.060 |
Why?
| | Prospective Studies | 1 | 2016 | 6189 | 0.060 |
Why?
| | Age Factors | 1 | 2012 | 2875 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2011 | 1378 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 2 | 2021 | 2269 | 0.050 |
Why?
| | Biomarkers | 1 | 2012 | 3389 | 0.050 |
Why?
| | Headache Disorders, Secondary | 1 | 2021 | 3 | 0.050 |
Why?
| | Bronchoalveolar Lavage | 1 | 2002 | 82 | 0.050 |
Why?
| | Neurologic Examination | 1 | 2021 | 111 | 0.050 |
Why?
| | Constipation | 1 | 2002 | 75 | 0.050 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2001 | 43 | 0.050 |
Why?
| | Reoviridae | 1 | 2001 | 35 | 0.050 |
Why?
| | Fatal Outcome | 1 | 2021 | 280 | 0.050 |
Why?
| | Endopeptidases | 1 | 2001 | 70 | 0.050 |
Why?
| | Prednisone | 1 | 2021 | 229 | 0.040 |
Why?
| | X Chromosome | 1 | 2000 | 47 | 0.040 |
Why?
| | Capsid | 1 | 2001 | 74 | 0.040 |
Why?
| | Capsid Proteins | 1 | 2001 | 67 | 0.040 |
Why?
| | Family Health | 1 | 2021 | 192 | 0.040 |
Why?
| | Agammaglobulinemia | 1 | 2000 | 30 | 0.040 |
Why?
| | Leucine | 1 | 2001 | 102 | 0.040 |
Why?
| | Migraine Disorders | 1 | 2021 | 82 | 0.040 |
Why?
| | Sucralfate | 1 | 2020 | 3 | 0.040 |
Why?
| | Arthritis, Infectious | 1 | 2000 | 49 | 0.040 |
Why?
| | Deglutition | 1 | 2020 | 58 | 0.040 |
Why?
| | Critical Pathways | 1 | 2020 | 74 | 0.040 |
Why?
| | Pneumococcal Infections | 1 | 2000 | 91 | 0.040 |
Why?
| | Needs Assessment | 1 | 2020 | 314 | 0.040 |
Why?
| | Information Dissemination | 1 | 2020 | 185 | 0.040 |
Why?
| | Interprofessional Relations | 1 | 2020 | 246 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2001 | 342 | 0.040 |
Why?
| | Nutrition Therapy | 1 | 2018 | 30 | 0.040 |
Why?
| | Eating | 1 | 2020 | 340 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2021 | 520 | 0.040 |
Why?
| | Program Evaluation | 1 | 2020 | 821 | 0.030 |
Why?
| | Time-to-Treatment | 1 | 2016 | 146 | 0.030 |
Why?
| | Animals | 2 | 2013 | 31162 | 0.030 |
Why?
| | Pandemics | 1 | 2020 | 1308 | 0.030 |
Why?
| | Time Factors | 1 | 2002 | 6032 | 0.020 |
Why?
| | Patient Care Team | 1 | 2016 | 518 | 0.020 |
Why?
| | Prednisolone | 1 | 2009 | 75 | 0.020 |
Why?
| | Algorithms | 1 | 2016 | 1462 | 0.020 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 528 | 0.010 |
Why?
| | Cathepsin L | 1 | 2001 | 9 | 0.010 |
Why?
| | Cathepsin D | 1 | 2001 | 14 | 0.010 |
Why?
| | Cathepsins | 1 | 2001 | 22 | 0.010 |
Why?
| | Cysteine Endopeptidases | 1 | 2001 | 59 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2009 | 4384 | 0.010 |
Why?
| | Virus Assembly | 1 | 2001 | 66 | 0.010 |
Why?
| | Risk Assessment | 1 | 2009 | 2953 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2001 | 497 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2000 | 289 | 0.010 |
Why?
| | Streptococcus pneumoniae | 1 | 2000 | 133 | 0.010 |
Why?
| | Knee Joint | 1 | 2000 | 321 | 0.010 |
Why?
| | Adaptation, Physiological | 1 | 2001 | 465 | 0.010 |
Why?
| | Mutation | 1 | 2001 | 3313 | 0.010 |
Why?
| | Mice | 1 | 2001 | 14679 | 0.000 |
Why?
|
|
Brumbaugh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|